Highlights

  • Jarryd Doran becomes Managing Director and CEO from 1 December 2026, with fixed pay unchanged at A$450,000 plus superannuation.
  • Adam Bloomer moves to Executive Director, Strategic Growth, focusing on strategy, investment, Capital allocation and growth opportunities.
  • Bloomer-controlled Blakin Technologies bought LGI shares on market through October, lifting its holding to 13,767,869 shares.
  • H1 FY26 net Revenue rose 21% to A$18.8 million, while statutory EBITDA climbed 33.1% to A$9.7 million.

LGI Limited (ASX:LGI) is reorganising its senior ranks, with Chief Executive Officer Jarryd Doran set to take on the additional title of Managing Director from 1 December 2026. The changes, announced on 14 October 2026, move current Managing Director Adam Bloomer into a new role as Executive Director, Strategic Growth, while Dr Jessica North steps from Executive Director to Non-Executive Director and Advisor.

The company captures biogas at landfills in Queensland, New South Wales and the ACT and converts it into renewable electricity and carbon abatement. Chairman Rod Duke said the moves reflect the continued evolution of its Leadership structure.

A Reshaped Executive Team From December

Doran's total fixed remuneration stays at A$450,000 plus Superannuation despite the added duties, and Bloomer's fixed pay is also unchanged. North will be paid on standard non-executive terms, plus an annual retainer of A$20,000 for mentoring and technical support.

Thomas O'Connor becomes Chief Operating Officer after three years as National Operations Manager, and Matthew Tap becomes Chief Development Officer after five years leading projects and innovation. Hasaka Martin returns as Company Secretary, replacing Priyamvada Rasal.

Long-Dated Options Put Retention at the Centre

Subject to Shareholder approval, Doran is to receive 1.8 million unlisted options with an exercise price of A$2.75 and an eight-year expiry. They replace his previously announced short- and long-term incentives and vest in four 25% tranches in years three, four, five and seven, conditional on continuous employment.

Selected executives and senior managers are set to receive a further 4,061,000 retention options at the same exercise price, vesting over eight years. Details will appear in the notice of the 2026 annual general meeting, for which LGI advised a rescheduled date on 24 September 2026.

Director Buying and a Late Disclosure

Blakin Technologies, which Bloomer controls, bought LGI shares on market repeatedly through October. A substantial holder notice dated 28 October 2026 showed a relevant interest of 13,729,591 shares and voting power of 13.27%, compared with 15.28% previously. A further purchase on 30 October lifted the holding to 13,767,869 shares.

On the same day, LGI lodged a late change-of-interest notice for North, who acquired a 50% stake in Blakin on 10 April 2026. The company said it would reinforce its internal notification procedures.

Earnings Base and the Road Ahead

In H1 FY26, the six months to 31 December 2025, net revenue rose 21% to A$18.8 million and net profit after tax climbed 28.4% to A$3.1 million. Biogas flows grew 37.4% to 82.0 million cubic metres and renewable generation rose 40.7% to 70,287 MWh. LGI held net cash of A$14.7 million at 31 December 2025 after repaying its bank project loan, and released its FY26 results on 21 August 2026.

The leadership changes are scheduled to take effect on 1 December 2026, while the option grants await shareholder votes. Shares were priced at A$2.58 on 2 November 2026, down 2.64% on the day, giving a Market Capitalisation of A$266.88 million.